1. Home
  2. LARK vs TARA Comparison

LARK vs TARA Comparison

Compare LARK & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Landmark Bancorp Inc.

LARK

Landmark Bancorp Inc.

HOLD

Current Price

$27.91

Market Cap

167.8M

Sector

Finance

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$6.84

Market Cap

165.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LARK
TARA
Founded
1885
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.8M
165.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LARK
TARA
Price
$27.91
$6.84
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$20.33
AVG Volume (30 Days)
8.4K
767.4K
Earning Date
10-29-2025
11-10-2025
Dividend Yield
2.86%
N/A
EPS Growth
38.73
N/A
EPS
2.84
N/A
Revenue
$64,367,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.83
N/A
Revenue Growth
12.95
N/A
52 Week Low
$20.99
$2.77
52 Week High
$29.56
$10.48

Technical Indicators

Market Signals
Indicator
LARK
TARA
Relative Strength Index (RSI) 58.84 59.93
Support Level $27.26 $6.21
Resistance Level $28.77 $7.14
Average True Range (ATR) 0.92 0.64
MACD 0.04 -0.02
Stochastic Oscillator 39.57 66.31

Price Performance

Historical Comparison
LARK
TARA

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Share on Social Networks: